Authors
Latest:
FDA OKs Biosimilar Adalimumab for Autoimmune ConditionsThe FDA has approved Sandoz’s biosimilar adalimumab, Hyrimoz (adalimumab-adaz) for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn disease, ulcerative colitis, and plaque psoriasis.
Latest:
Are PBMs the Big Bad Wolf?Pharmacy benefit managers are a large part of our health care benefits, but do they bring value?
Latest:
Pain Management in End-Stage Renal DiseaseRecently we have received an increasing number of requests for consults on patients undergoing hemodialysis (HD) or with end-stage renal disease (ESRD).
Latest:
Liraglutide (Victoza): A Quick Guide for PharmacistsWhat role does this medication play in diabetes therapy, and what are its clinical benefits, compared with competitors?
Latest:
What Are Treatment Approaches to Liver Cancer?How to treat hepatocellular carcinoma is heavily influenced by the burden of disease at diagnosis.
Latest:
Adherence With Lipid-Lowering, Antihypertensive, and Diabetes MedicationsAdherence was examined among patients taking medications, individually and in combinations, to treat hypertension, hyperlipidemia, and/or diabetes.
Latest:
Hypertension Treatment Guidelines UpdateHealth care providers often encounter patients with high blood pressure, especially systolic, who come and go without proper treatment and eventually end up in the hospital with a heart attack, kidney failure, or a stroke.
Latest:
Educational Pharmacogenetics Resources for PharmacistsThe utility of pharmacogenetic testing has exponentially increased within the past few years.
Latest:
Impact of Initial Days' Supply of Angiotensin II Receptor BlockersFor ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.
Latest:
Working Outside the Dispensing Box: The Roles of the Medical Information Specialist and Medical Science LiaisonAs medical information specialists and medical science liaisons, pharmacists use their drug expertise and clinical skills to serve as information providers
Latest:
Jack Dalton Named Market Health and Wellness Director of the YearAs Market Health and Wellness Director for Market 331 in Las Vegas, Nevada, Jack Dalton exceeds expectations.
Latest:
Herpes Zoster: Talking Points on the New Vaccine for PatientsThe pharmacist is in a key position to assess and communicate about a patient’s specific vaccine needs.
Latest:
Debate Continues to Swirl Around Right to Try LawsForms of right to try legislation have already been passed in 39 states, as well as in the House of Representatives and Senate.
Latest:
Bilateral Psoas Abscess Treated with Multiple Antibiotic RegimensAbscesses can occur in obscure places in the body, including the psoas muscle.
Latest:
Overcoming Challenges of Insulin Therapy in Type 2 Diabetes: Exploring Emerging OptionsThis Continuing Education activity is supported by an educational grant from Sanofi-Aventis U.S.
Latest:
Provision of Diabetes Sick-Day Plans in the Community PharmacyAs community pharmacists, we are often the most accessible members of the health care team.
Latest:
Specialty Pharmaceuticals: Therapy Class Review: Macular DegenerationWith the novel agents in the age-related macular degeneration pipeline, drug makers are taking advantage of an opportunity for innovation.
Latest:
Analyzing the Impact of Different Value-Based Insurance Design ProgramsTotal 1-year healthcare costs were not significantly reduced by 2 value-based insurance design programs for diabetic patients, although education appeared to improve quality of care.
Latest:
Working Together to Distinguish Hospital, Health System Specialty Pharmacy ServicesHow health system specialty pharmacies can leverage data to differentiate the impact of the high-touch, integrated care model and create value for all pharmacy stakeholders.
Latest:
Modeled Cost Differences Associated With Use of Levonorgestrel Intrauterine DevicesThis analytic model assessed the per-woman cost differences between the use of 2 levonorgestrel-releasing intrauterine devices, from a US payer perspective.
Latest:
Sun Protection: Pharmacists Have the FactsChoosing the right sun protection option can be more complicated than it was in the past.
Latest:
Drug Review: Daklinza for Chronic Hepatitis C InfectionAn overview of Daklinza (daclatasvir) for pharmacists.
